The chemical biology of IL-12 productionviathe non-canonical NFkB pathway
Author:
Affiliation:
1. Center for Systems Biology
2. Massachusetts General Hospital
3. Boston
4. USA
5. Department of Systems Biology
Abstract
Interleukin-12 (IL-12) has emerged as an attractive cytokine for cancer therapy because it has direct anti-cancer effects and additionally plays a critical role in enhancing checkpoint inhibitors.
Funder
National Cancer Institute
National Institute of Allergy and Infectious Diseases
Publisher
Royal Society of Chemistry (RSC)
Link
http://pubs.rsc.org/en/content/articlepdf/2020/CB/D0CB00022A
Reference117 articles.
1. Testimony from the Bedside: From Coley's Toxins to Targeted Immunotherapy
2. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
3. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
4. Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
5. Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lipid Nanoparticle‐mRNA Engineered Dendritic Cell Based Adoptive Cell Therapy Enhances Cancer Immune Response;Small Methods;2024-07-23
2. Two transcriptionally and functionally distinct waves of neutrophils during mouse acute liver injury;Hepatology Communications;2024-06-19
3. Royal Jelly: Biological Action and Health Benefits;International Journal of Molecular Sciences;2024-05-30
4. Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype;Frontiers in Immunology;2024-03-13
5. Systemic immune response to a CD40 agonist antibody in nonhuman primates;Journal of Leukocyte Biology;2024-02-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3